Rockwell Medical Q2 net sales up 11% to $17.8M; net loss narrows to $1.2M

ROCKWELL MEDICAL, INC.

Net sales $17.8M, +11% YoY; gross profit $3.2M, +30%; gross margin 18% vs 16%.
Net loss $1.2M vs $1.5M loss; adjusted EBITDA -$0.2M; cash $24.8M at June 30.
Reiterates 2026 guidance: net sales $70-75M, gross margin 18-22%, adj EBITDA $1-2M.
1-for-10 reverse stock split effective July 1, 2026; regained Nasdaq compliance.
New/expanded agreements with Heritage Dialysis and aQua Dialysis during Q2.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.